1. Home
  2. PPBT vs APVO Comparison

PPBT vs APVO Comparison

Compare PPBT & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PPBT
  • APVO
  • Stock Information
  • Founded
  • PPBT 2010
  • APVO 2016
  • Country
  • PPBT Israel
  • APVO United States
  • Employees
  • PPBT N/A
  • APVO N/A
  • Industry
  • PPBT Biotechnology: Pharmaceutical Preparations
  • APVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • PPBT Health Care
  • APVO Health Care
  • Exchange
  • PPBT Nasdaq
  • APVO Nasdaq
  • Market Cap
  • PPBT 8.7M
  • APVO 5.4M
  • IPO Year
  • PPBT N/A
  • APVO N/A
  • Fundamental
  • Price
  • PPBT $3.10
  • APVO $3.34
  • Analyst Decision
  • PPBT Strong Buy
  • APVO Strong Buy
  • Analyst Count
  • PPBT 2
  • APVO 1
  • Target Price
  • PPBT $126.50
  • APVO $296.00
  • AVG Volume (30 Days)
  • PPBT 28.8K
  • APVO 45.6K
  • Earning Date
  • PPBT 03-04-2025
  • APVO 03-04-2025
  • Dividend Yield
  • PPBT N/A
  • APVO N/A
  • EPS Growth
  • PPBT N/A
  • APVO N/A
  • EPS
  • PPBT N/A
  • APVO N/A
  • Revenue
  • PPBT N/A
  • APVO N/A
  • Revenue This Year
  • PPBT N/A
  • APVO N/A
  • Revenue Next Year
  • PPBT N/A
  • APVO N/A
  • P/E Ratio
  • PPBT N/A
  • APVO N/A
  • Revenue Growth
  • PPBT N/A
  • APVO N/A
  • 52 Week Low
  • PPBT $2.00
  • APVO $3.01
  • 52 Week High
  • PPBT $20.60
  • APVO $399.60
  • Technical
  • Relative Strength Index (RSI)
  • PPBT 41.53
  • APVO 28.65
  • Support Level
  • PPBT $2.90
  • APVO $3.77
  • Resistance Level
  • PPBT $3.20
  • APVO $4.47
  • Average True Range (ATR)
  • PPBT 0.21
  • APVO 0.33
  • MACD
  • PPBT 0.00
  • APVO -0.01
  • Stochastic Oscillator
  • PPBT 42.19
  • APVO 19.64

About PPBT Purple Biotech Ltd.

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.

About APVO Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.

Share on Social Networks: